NOS3 and Pulmonary artery stenosis: L-NAME, an eNOS inhibitor, abolished the inhibitory effect of rBMSC/Cav-1F92A on RVSP and pulmonary artery stenosis (Figures 1(b) and 1(c) and Figure 2).